Alterola Biotech (Alterola Biotech) LT-Debt-to-Total-Asset : 0.00 (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Alterola Biotech LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Alterola Biotech's long-term debt to total assests ratio for the quarter that ended in Dec. 2023 was 0.00.

Alterola Biotech's long-term debt to total assets ratio declined from Dec. 2022 (0.01) to Dec. 2023 (0.00). It may suggest that Alterola Biotech is progressively becoming less dependent on debt to grow their business.

Alterola Biotech LT-Debt-to-Total-Asset Historical Data

The historical data trend for Alterola Biotech's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alterola Biotech LT-Debt-to-Total-Asset Chart

Alterola Biotech Annual Data

Trend

Sep13

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Mar22

Mar23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.39

0.01

Alterola Biotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.01	0.01	-	-	-

Alterola Biotech LT-Debt-to-Total-Asset Calculation

Alterola Biotech's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2023 is calculated as

LT Debt to Total Assets (A: Mar. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Mar. 2023 )	/	Total Assets (A: Mar. 2023 )
	=	0.154	/	12.377
	=

Alterola Biotech's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (Q: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2023 )	/	Total Assets (Q: Dec. 2023 )
	=	0	/	0.004
	=

Alterola Biotech (OTCPK:ABTI) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Alterola Biotech LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Alterola Biotech's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Alterola Biotech (Alterola Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alterola Biotech Inc (OTCPK:ABTI) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

47 Hamilton Square, Birkenhead, Merseyside, GBR, CH41 5AR

Website

https://www.alterolabio.com

Alterola Biotech Inc is a development stage company. The company develops chewing gums to deliver nutraceutical/functional ingredients for applications such as appetite suppressant, cholesterol suppressant, vitamin delivery, antioxidant delivery, and motion sickness suppressant.

Executives

Bright Green Corp

10 percent owner

401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301